GVIRX
Price
$18.55
Change
+$0.06 (+0.32%)
Updated
Sep 15 closing price
Net Assets
3.68B
JEPRX
Price
$14.11
Change
-$0.03 (-0.21%)
Updated
Sep 15 closing price
Net Assets
6.36B
Interact to see
Advertisement

GVIRX vs JEPRX

Header iconGVIRX vs JEPRX Comparison
Open Charts GVIRX vs JEPRXBanner chart's image
Goldman Sachs US Eq Div and Premium I
Price$18.55
Change+$0.06 (+0.32%)
VolumeN/A
Net Assets3.68B
JPMorgan Equity Premium Income R6
Price$14.11
Change-$0.03 (-0.21%)
VolumeN/A
Net Assets6.36B
GVIRX vs JEPRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GVIRX vs. JEPRX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVIRX is a StrongBuy and JEPRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JEPRX has more cash in the bank: 6.36B vs. GVIRX (3.68B). JEPRX pays higher dividends than GVIRX: JEPRX (8.55) vs GVIRX (1.08). GVIRX was incepted earlier than JEPRX: GVIRX (15 years) vs JEPRX (7 years). GVIRX (0.86) is less costly to investors than JEPRX (0.35). JEPRX is a more actively managed with annual turnover of: 176.00 vs. GVIRX (23.00). GVIRX has a lower initial minimum investment than JEPRX: GVIRX (0) vs JEPRX (15000000). GVIRX annual gain was more profitable for investors over the last year : 8.81 vs. JEPRX (5.23). JEPRX return over 5 years is better than : 64.71 vs. GVIRX (43.84).
GVIRXJEPRXGVIRX / JEPRX
Total Expense Ratio0.760.35217%
Annual Report Gross Expense Ratio0.860.35246%
Fund Existence15 years7 years-
Gain YTD9.3634.456210%
Front LoadN/AN/A-
Min. Initial Investment015000000-
Min. Initial Investment IRAN/AN/A-
Net Assets3.68B6.36B58%
Annual Yield % from dividends1.088.5513%
Returns for 1 year8.815.23168%
Returns for 3 years39.0336.22108%
Returns for 5 years43.8464.7168%
Returns for 10 years86.55N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GQLOX35.48N/A
N/A
GMO Quality VI
PCLVX23.00N/A
N/A
PACE Large Co Value Equity P
AVUGX8.50N/A
N/A
American Century Value R5
NSCRX53.73N/A
N/A
Nuveen Small-Cap Value Opps I
MDODX11.76N/A
N/A
Morgan Stanley Developing Opportunity R6